Anticholinergic Therapy for Overactive Bladder in Parkinson's Disease

NCT00892450 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

FED

Sponsor class

Conditions

Parkinson's Disease
Overactive Bladder

Interventions

DRUG: Oxybutynin and darifenacin

Sponsor

US Department of Veterans Affairs